A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19
Liu, Wang-Da, Feng, Po-Hao, Cheng, Chien-Yu, Chou, Chun-Liang, Lee, Chih-Hsin, Lu, Min-Chi, Liu, Po-Yu, Lee, Mei-Hui, Liao, Chun-Hsing, Chen, Mei-Chuan, Chen, Cheng-Pin, Hsu, Shang-Fu, Tzeng, Yu-Tien, Lin, Yi-Chun, Ou, Tsong-Yih, Qin, Albert, Tsai, Chan-Yen, Shih, Weichung Joe, Lee, Kang-Yun, Sheng, Wang-Huei
Published in Infectious diseases and therapy (01.07.2024)
Published in Infectious diseases and therapy (01.07.2024)
Get full text
Journal Article